JP2005533052A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005533052A5 JP2005533052A5 JP2004511297A JP2004511297A JP2005533052A5 JP 2005533052 A5 JP2005533052 A5 JP 2005533052A5 JP 2004511297 A JP2004511297 A JP 2004511297A JP 2004511297 A JP2004511297 A JP 2004511297A JP 2005533052 A5 JP2005533052 A5 JP 2005533052A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- alkoxy
- hydrogen
- substituted
- cyano
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 33
- -1 1-azabicyclo [2.2.2] oct-3-yl Chemical group 0.000 claims 29
- 239000012453 solvate Substances 0.000 claims 26
- 239000001257 hydrogen Substances 0.000 claims 25
- 229910052739 hydrogen Inorganic materials 0.000 claims 25
- 229910052736 halogen Inorganic materials 0.000 claims 23
- 150000002367 halogens Chemical class 0.000 claims 23
- 150000003839 salts Chemical class 0.000 claims 21
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 20
- 150000002431 hydrogen Chemical class 0.000 claims 17
- 125000000623 heterocyclic group Chemical group 0.000 claims 16
- 125000004093 cyano group Chemical group *C#N 0.000 claims 14
- 125000000732 arylene group Chemical group 0.000 claims 12
- 125000005549 heteroarylene group Chemical group 0.000 claims 12
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 10
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 claims 10
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 7
- 229910052760 oxygen Inorganic materials 0.000 claims 7
- 239000001301 oxygen Substances 0.000 claims 7
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims 6
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims 6
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 6
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims 6
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims 6
- 229910052794 bromium Inorganic materials 0.000 claims 6
- 229910052801 chlorine Inorganic materials 0.000 claims 6
- 239000000460 chlorine Substances 0.000 claims 6
- ORTFAQDWJHRMNX-UHFFFAOYSA-N hydroxidooxidocarbon(.) Chemical group O[C]=O ORTFAQDWJHRMNX-UHFFFAOYSA-N 0.000 claims 6
- SNOOUWRIMMFWNE-UHFFFAOYSA-M sodium;6-[(3,4,5-trimethoxybenzoyl)amino]hexanoate Chemical compound [Na+].COC1=CC(C(=O)NCCCCCC([O-])=O)=CC(OC)=C1OC SNOOUWRIMMFWNE-UHFFFAOYSA-M 0.000 claims 6
- 229910052717 sulfur Inorganic materials 0.000 claims 6
- 239000011593 sulfur Substances 0.000 claims 6
- 125000000217 alkyl group Chemical group 0.000 claims 5
- 125000005605 benzo group Chemical group 0.000 claims 5
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 claims 5
- 125000004760 (C1-C4) alkylsulfonylamino group Chemical group 0.000 claims 4
- 125000004890 (C1-C6) alkylamino group Chemical group 0.000 claims 4
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims 4
- 125000003118 aryl group Chemical group 0.000 claims 4
- 229910052731 fluorine Inorganic materials 0.000 claims 4
- 239000011737 fluorine Substances 0.000 claims 4
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 claims 4
- 238000000034 method Methods 0.000 claims 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 4
- 125000000168 pyrrolyl group Chemical group 0.000 claims 4
- 125000004916 (C1-C6) alkylcarbonyl group Chemical group 0.000 claims 3
- 125000006700 (C1-C6) alkylthio group Chemical group 0.000 claims 3
- 239000003814 drug Substances 0.000 claims 3
- 125000005224 heteroarylcarbonylamino group Chemical group 0.000 claims 3
- 230000008447 perception Effects 0.000 claims 3
- 125000004454 (C1-C6) alkoxycarbonyl group Chemical group 0.000 claims 2
- 125000003830 C1- C4 alkylcarbonylamino group Chemical group 0.000 claims 2
- 239000002253 acid Substances 0.000 claims 2
- 125000004202 aminomethyl group Chemical group [H]N([H])C([H])([H])* 0.000 claims 2
- 125000005842 heteroatom Chemical group 0.000 claims 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 2
- 239000011630 iodine Substances 0.000 claims 2
- 229910052740 iodine Inorganic materials 0.000 claims 2
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 2
- 229910052757 nitrogen Inorganic materials 0.000 claims 2
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 2
- 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 claims 2
- 239000002904 solvent Substances 0.000 claims 2
- ITMCEJHCFYSIIV-UHFFFAOYSA-M triflate Chemical compound [O-]S(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-M 0.000 claims 2
- 125000004070 6 membered heterocyclic group Chemical group 0.000 claims 1
- LELOWRISYMNNSU-UHFFFAOYSA-N Hydrocyanic acid Natural products N#C LELOWRISYMNNSU-UHFFFAOYSA-N 0.000 claims 1
- WXLPFZKLJWNZSL-UHFFFAOYSA-N [N].C1CC2CCN1CC2 Chemical group [N].C1CC2CCN1CC2 WXLPFZKLJWNZSL-UHFFFAOYSA-N 0.000 claims 1
- 125000003545 alkoxy group Chemical group 0.000 claims 1
- 229940100198 alkylating agent Drugs 0.000 claims 1
- 239000002168 alkylating agent Substances 0.000 claims 1
- 230000002152 alkylating effect Effects 0.000 claims 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 1
- 230000006806 disease prevention Effects 0.000 claims 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 1
- 231100000252 nontoxic Toxicity 0.000 claims 1
- 230000003000 nontoxic effect Effects 0.000 claims 1
- 239000007800 oxidant agent Substances 0.000 claims 1
- 230000001590 oxidative effect Effects 0.000 claims 1
- 125000001820 oxy group Chemical group [*:1]O[*:2] 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 1
- SBYHFKPVCBCYGV-UHFFFAOYSA-N quinuclidine Chemical compound C1CC2CCN1CC2 SBYHFKPVCBCYGV-UHFFFAOYSA-N 0.000 claims 1
- XFMMLGKPCUIDRC-NRFANRHFSA-N CCNC(Nc1cc(-c2c3[o]c(C(N[C@@H]4C(CC5)CCN5C4)=O)cc3ccc2)ccc1)=O Chemical compound CCNC(Nc1cc(-c2c3[o]c(C(N[C@@H]4C(CC5)CCN5C4)=O)cc3ccc2)ccc1)=O XFMMLGKPCUIDRC-NRFANRHFSA-N 0.000 description 1
- PTGBVENXNHSJDH-NRFANRHFSA-N CNC(NCc(cccc1)c1-c1c2[s]c(C(N[C@@H]3C(CC4)CCN4C3)=O)cc2ccc1)=O Chemical compound CNC(NCc(cccc1)c1-c1c2[s]c(C(N[C@@H]3C(CC4)CCN4C3)=O)cc2ccc1)=O PTGBVENXNHSJDH-NRFANRHFSA-N 0.000 description 1
- BLMCISDZRAKABM-VJIACCKLSA-N COc1ccccc1-c1c2[o]c(C(/C=C\[C@@H]3C(CC4)CCN4C3)=O)cc2ccc1 Chemical compound COc1ccccc1-c1c2[o]c(C(/C=C\[C@@H]3C(CC4)CCN4C3)=O)cc2ccc1 BLMCISDZRAKABM-VJIACCKLSA-N 0.000 description 1
- IXGZNFXWAMPYSK-IBDYFIJFSA-N NCc(cccc1)c1-c1c2[s]c(C(/C=C/[C@@H]3C(CC4)CCN4C3)=O)cc2ccc1 Chemical compound NCc(cccc1)c1-c1c2[s]c(C(/C=C/[C@@H]3C(CC4)CCN4C3)=O)cc2ccc1 IXGZNFXWAMPYSK-IBDYFIJFSA-N 0.000 description 1
- XFVZCRRNVIQYSD-OUZREKFBSA-N O=C(/C=C/[C@@H]1C(CC2)CCN2C1)c1cc2cccc(-c(cc3)ccc3N(CCOC3)C3=O)c2[o]1 Chemical compound O=C(/C=C/[C@@H]1C(CC2)CCN2C1)c1cc2cccc(-c(cc3)ccc3N(CCOC3)C3=O)c2[o]1 XFVZCRRNVIQYSD-OUZREKFBSA-N 0.000 description 1
- GHNCIOFKCQPWIS-QFIPXVFZSA-N O=C(C1CC1)Nc1cc(-c2c3[o]c(C(N[C@@H]4C(CC5)CCN5C4)=O)cc3ccc2)ccc1 Chemical compound O=C(C1CC1)Nc1cc(-c2c3[o]c(C(N[C@@H]4C(CC5)CCN5C4)=O)cc3ccc2)ccc1 GHNCIOFKCQPWIS-QFIPXVFZSA-N 0.000 description 1
- WGSQXNGRRPBLHT-NRFANRHFSA-N OC(c1cc(-c2c3[s]c(C(CCC[C@@H]4C(CC5)CCN5C4)=O)cc3ccc2)ccc1)=O Chemical compound OC(c1cc(-c2c3[s]c(C(CCC[C@@H]4C(CC5)CCN5C4)=O)cc3ccc2)ccc1)=O WGSQXNGRRPBLHT-NRFANRHFSA-N 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10225536 | 2002-06-10 | ||
| DE10257078A DE10257078A1 (de) | 2002-12-06 | 2002-12-06 | 2-Heteroarylcarbonsäureamide |
| DE2002157537 DE10257537A1 (de) | 2002-12-10 | 2002-12-10 | 2-Heteroarylcarbonsäureamide |
| DE10305922A DE10305922A1 (de) | 2002-06-10 | 2003-02-13 | 2-Heteroarylcarbonsäureamide |
| PCT/EP2003/005735 WO2003104227A1 (de) | 2002-01-20 | 2003-06-02 | 2-heteroarylcarbonsäureamide |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2005533052A JP2005533052A (ja) | 2005-11-04 |
| JP2005533052A5 true JP2005533052A5 (https=) | 2006-07-20 |
| JP4542891B2 JP4542891B2 (ja) | 2010-09-15 |
Family
ID=29740887
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004511297A Expired - Fee Related JP4542891B2 (ja) | 2002-06-10 | 2003-06-02 | ２−ヘテロアリールカルボキサミド類 |
Country Status (16)
| Country | Link |
|---|---|
| US (5) | US7977485B2 (https=) |
| EP (1) | EP1515967B1 (https=) |
| JP (1) | JP4542891B2 (https=) |
| CN (1) | CN1675204A (https=) |
| AT (1) | ATE344262T1 (https=) |
| AU (1) | AU2003238450A1 (https=) |
| BR (1) | BR0312446A (https=) |
| CA (1) | CA2488761C (https=) |
| DE (1) | DE50305587D1 (https=) |
| ES (1) | ES2276072T3 (https=) |
| IL (1) | IL165505A0 (https=) |
| MX (1) | MXPA04012439A (https=) |
| NO (1) | NO20050063L (https=) |
| PL (1) | PL374551A1 (https=) |
| UY (1) | UY27841A1 (https=) |
| WO (1) | WO2003104227A1 (https=) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10164139A1 (de) | 2001-12-27 | 2003-07-10 | Bayer Ag | 2-Heteroarylcarbonsäureamide |
| MXPA04012439A (es) * | 2002-06-10 | 2005-04-19 | Bayer Healthcare Ag | Amidas de acidos 2-heteroarilcarboxilicos. |
| MXPA05003317A (es) * | 2002-09-25 | 2005-07-05 | Memory Pharm Corp | Indazoles, benzotiazoles y benzoisotiazoles asi como preparacion y usos de los mismos. |
| WO2005016923A1 (en) | 2003-08-13 | 2005-02-24 | Neurosearch A/S | Novel quinuclidine derivatives and their pharmaceutical use |
| RU2389729C2 (ru) * | 2003-12-22 | 2010-05-20 | Мемори Фармасьютиклз Корпорейшн | 1н-индазолы, 1, 2-бензизоксазолы и 1, 2-бензизотиазолы, их получение и применение |
| EP1735306A2 (en) | 2004-03-25 | 2006-12-27 | Memory Pharmaceuticals Corporation | Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, and preparation and uses thereof |
| US7514450B2 (en) | 2004-05-19 | 2009-04-07 | Neurosearch A/S | Azabicyclic aryl derivatives |
| DE602005025902D1 (de) | 2004-10-15 | 2011-02-24 | Neurosearch As | Neue azabizyklische arylderivate und medizinische verwendung damit |
| US8106066B2 (en) * | 2005-09-23 | 2012-01-31 | Memory Pharmaceuticals Corporation | Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, pyrazolopyridines, isothiazolopyridines, and preparation and uses thereof |
| CN101910159B (zh) * | 2007-12-26 | 2013-06-19 | 卫材R&D管理有限公司 | 杂环取代吡啶衍生物的制备方法 |
| US8367676B2 (en) * | 2009-06-30 | 2013-02-05 | Astrazeneca Ab | 2-carboxamide-7-piperazinyl-benzofuran derivatives 774 |
| PE20170923A1 (es) | 2010-05-17 | 2017-07-12 | Forum Pharmaceuticals Inc | Una forma cristalina de clorhidrato de (r)-7-cloro-n-(quinuclidin-3-il)benzo[b]tiofeno-2-carboxamida monohidratado |
| CN103380129B (zh) | 2010-12-20 | 2016-04-20 | 阿克图拉姆生命科学股份公司 | 2-甲酰胺-4-哌嗪基-苯并呋喃衍生物 |
| KR101928505B1 (ko) * | 2011-01-28 | 2018-12-12 | 에스케이바이오팜 주식회사 | 피리돈 유도체 및 이를 포함하는 약학적 조성물 |
| EP3461481A1 (en) | 2012-05-08 | 2019-04-03 | Forum Pharmaceuticals Inc. | Methods of maintaining, treating or improving cognitive function |
| CN111205283A (zh) * | 2020-01-20 | 2020-05-29 | 广州九植医药科技有限公司 | 一种盐酸帕洛诺司琼有关物质b的合成方法 |
| CN111205284A (zh) * | 2020-01-20 | 2020-05-29 | 广州九植医药科技有限公司 | 一种盐酸帕洛诺司琼有关物质a的合成方法 |
| US20230391758A1 (en) * | 2020-09-18 | 2023-12-07 | Merck Sharp & Dohme Llc | Modified benzofuran-carboxamides as glucosylceramide synthase inhibitors |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE0000540D0 (sv) * | 2000-02-18 | 2000-02-18 | Astrazeneca Ab | New compounds |
| JP4616971B2 (ja) * | 2000-07-18 | 2011-01-19 | 田辺三菱製薬株式会社 | １−アザビシクロアルカン化合物およびその医薬用途 |
| AR036040A1 (es) * | 2001-06-12 | 2004-08-04 | Upjohn Co | Compuestos de heteroarilo multiciclicos sustituidos con quinuclidinas y composiciones farmaceuticas que los contienen |
| CA2462453C (en) | 2001-10-02 | 2009-07-28 | Pharmacia & Upjohn Company | Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease |
| DE10164139A1 (de) * | 2001-12-27 | 2003-07-10 | Bayer Ag | 2-Heteroarylcarbonsäureamide |
| MXPA04012439A (es) * | 2002-06-10 | 2005-04-19 | Bayer Healthcare Ag | Amidas de acidos 2-heteroarilcarboxilicos. |
| DE10234424A1 (de) | 2002-07-29 | 2004-02-12 | Bayer Ag | Benzothiophen-, Benzofuran- und Indolharnstoffe |
-
2003
- 2003-06-02 MX MXPA04012439A patent/MXPA04012439A/es unknown
- 2003-06-02 JP JP2004511297A patent/JP4542891B2/ja not_active Expired - Fee Related
- 2003-06-02 CA CA2488761A patent/CA2488761C/en not_active Expired - Fee Related
- 2003-06-02 BR BR0312446-0A patent/BR0312446A/pt not_active Application Discontinuation
- 2003-06-02 PL PL03374551A patent/PL374551A1/xx not_active Application Discontinuation
- 2003-06-02 EP EP03732517A patent/EP1515967B1/de not_active Expired - Lifetime
- 2003-06-02 AT AT03732517T patent/ATE344262T1/de not_active IP Right Cessation
- 2003-06-02 US US10/516,777 patent/US7977485B2/en not_active Expired - Fee Related
- 2003-06-02 AU AU2003238450A patent/AU2003238450A1/en not_active Abandoned
- 2003-06-02 DE DE50305587T patent/DE50305587D1/de not_active Expired - Lifetime
- 2003-06-02 WO PCT/EP2003/005735 patent/WO2003104227A1/de not_active Ceased
- 2003-06-02 ES ES03732517T patent/ES2276072T3/es not_active Expired - Lifetime
- 2003-06-02 CN CNA038188511A patent/CN1675204A/zh active Pending
- 2003-06-10 UY UY27841A patent/UY27841A1/es not_active Application Discontinuation
-
2004
- 2004-12-02 IL IL16550504A patent/IL165505A0/xx unknown
-
2005
- 2005-01-06 NO NO20050063A patent/NO20050063L/no not_active Application Discontinuation
-
2011
- 2011-07-11 US US13/179,957 patent/US20110263591A1/en not_active Abandoned
-
2012
- 2012-03-06 US US13/412,946 patent/US20120258964A1/en not_active Abandoned
-
2014
- 2014-04-25 US US14/261,616 patent/US9067931B2/en not_active Expired - Fee Related
-
2015
- 2015-06-08 US US14/733,804 patent/US10214524B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005533052A5 (https=) | ||
| JP2006502119A5 (https=) | ||
| JP2008513498A5 (https=) | ||
| JP2007531744A5 (https=) | ||
| JP2010155827A5 (https=) | ||
| JP2004516314A5 (https=) | ||
| RU2000104863A (ru) | Производные 1,2,4-триазоло[4,3-b]пиридо[3,2-d]пиридазина и фармацевтические композиции, содержащие их | |
| JP2008526999A5 (https=) | ||
| JP2009536620A5 (https=) | ||
| JP2006527776A5 (https=) | ||
| JP2009511490A5 (https=) | ||
| JP2005538111A5 (https=) | ||
| AR051780A1 (es) | Compuestos en anillo fusionados que contienen nitrogeno y utilizacion de los mismos | |
| JP2005504055A5 (https=) | ||
| JP2006509749A5 (https=) | ||
| JP2019519586A5 (https=) | ||
| RU2005104434A (ru) | Производные 1-гетероциклилалкил-3-сульфонилиндола или - индазола как лиганды 5-гидрокситриптамина-6 | |
| RU2007101653A (ru) | Производные 1-азабицикло[3.3.1]нонанов | |
| JP2002030084A5 (https=) | ||
| JP2013510178A5 (https=) | ||
| JP2008517913A5 (https=) | ||
| JP2006508979A5 (https=) | ||
| JP2018510202A5 (https=) | ||
| JP2015522592A5 (https=) | ||
| JP2005527521A5 (https=) |